GlassScriptPhysician profile
Allison Tobar
NPI 1780143586
$1,681.60
in general payments reported to CMS, 2019-2025
19 companies · $388 in 2025
The $388 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $36.00 · 2023: $75.96 · 2024: $1,182 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,645.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $287.76 | 2024 | Jardiance |
| Merck Sharp & Dohme LLC | $200.43 | 2024-2025 | Verquvo, Winrevair |
| Pfizer INC. | $190.08 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $153.91 | 2024-2025 | Farxiga, Wainua |
| Boston Scientific Corporation | $153.64 | 2023-2025 | Zoom Wireless Transmitter, Watchman Flx, General - Therapies |
| Biosense Webster, INC. | $144.20 | 2024 | Carto 3 |
| Novartis Pharmaceuticals Corporation | $112.43 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $74.45 | 2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $48.03 | 2025 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $45.36 | 2024-2025 | Lifevest |
| Amgen INC. | $41.85 | 2024 | Repatha |
| Esperion Therapeutics, INC. | $38.54 | 2024 | Nexletol |
| Medtronic, INC. | $36.00 | 2022 | |
| Scpharmaceuticals INC. | $28.11 | 2024 | |
| Bridgebio Pharma, INC. | $27.81 | 2025 | Attruby |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $27.27 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $26.66 | 2024 | Arcalyst |
| Cvrx, INC. | $26.00 | 2025 | Barostim Neo System |
| Lilly USA, LLC | $19.07 | 2025 | Zepbound, Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Tobar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.